Clinical Trial Update: The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intravenous anidulafungin for invasive candidiasis has completed. The study assessed safety and effectiveness in patients with this i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Candidiasis

Drugs mentioned

• Anidulafungin (anidulafungin)

Snippet

Sponsor: Pfizer | Conditions: Candidiasis | Phase 2 | Status: COMPLETED